| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
7e-05 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0001 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |